Tenax Therapeutics (TENX) Earnings Date & Reports

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

TENX is expected to report earnings to rise 2.66% to -35 cents per share on November 18

Tenax Therapeutics TENX Stock Earnings Reports

Q3'26

Est.

$-0.36

Q1'26

Missed

by $0.12

Q4'25

Missed

by $0.15

Q3'25

Missed

by $0.17

Q2'25

Missed

by $0.06

The last earnings report on May 12 showed earnings per share of -34 cents, missing the estimate of -23 cents. With 4.58M shares outstanding, the current market capitalization sits at 71.11M.

View a ticker or compare two or three

TENX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for TENX